Bharat Parenterals Shareholders Approve Preferential Issue and Investment Limits at EGM
Bharat Parenterals Ltd 路 Others (Uncategorized) 路 25 Oct 2026, 8:07 pm
Bharat Parenterals Shareholders Approve Preferential Issue and Investment Limits at EGM Bharat Parenterals Limited announced that shareholders approved all special resolutions at the EGM held on 23rd Oct'26 with 100% majority of polled votes. The approved items include the preferential issuance of equity shares and authorization for investments, loans, guarantees, and securities exceeding limits under Section 186(2) of the Companies Act, 2013. A total of 4,879,194 votes were polled (78.71% of outstanding shares), all cast in favor via remote e-voting. A revised filing was submitted on 25th Oct'26 to correct shareholder categorization without altering vote tallies.
Original exchange filing (PDF)
More announcements from Bharat Parenterals Ltd
- Intimation for receipt of Establishment Inspection Report from US FDA by Innoxel Lifesciences Pvt Ltd., a subsidiary company of Bharat Parenterals Limited. 路 05 Nov 2026
- Transcript of Earnings Conference Call of Q2FY27. 路 02 Nov 2026
- Audio Recording of Q2FY27 Earnings Conference Call. 路 30 Oct 2026
- Investor Presentation for the Quarter and Half Year ended on September 30, 2026. 路 29 Oct 2026
- Un-Audited Standalone and Consolidated Financial Results For the Quarter and Half Year Ended On September 30, 2026. 路 29 Oct 2026
- Outcome of the Meeting of the Board of Director of Bharat Parenterals Limited held on October 29, 2026 路 29 Oct 2026
- Revised Voting Result 路 25 Oct 2026
- Approval of Preferential Issue by shareholders of the company through EGM held on October 23, 2026. 路 24 Oct 2026
